TIPE2 and hepatocellular carcinoma: Our data showed that TIPE2 mRNA is superior to AFP for diagnosing HBV-associated HCC from CHB and LC patients, while the combination of TIPE2 mRNA and AFP conferred no advantage over TIPE2 mRNA alone for detecting HBV-associated HCC from CHB and LC patients.